ZFIN ID: ZDB-PUB-180808-7
Zebrafish type I collagen mutants faithfully recapitulate human type I collagenopathies
Gistelinck, C., Kwon, R.Y., Malfait, F., Symoens, S., Harris, M.P., Henke, K., Hawkins, M.B., Fisher, S., Sips, P., Guillemyn, B., Bek, J.W., Vermassen, P., De Saffel, H., Witten, P.E., Weis, M., De Paepe, A., Eyre, D.R., Willaert, A., Coucke, P.J.
Date: 2018
Source: Proceedings of the National Academy of Sciences of the United States of America   115(34): E8037-E8046 (Journal)
Registered Authors: Coucke, Paul, Fisher, Shannon, Harris, Matthew, Henke, Katrin, Kwon, Ronald, Willaert, Andy, Witten, P. Eckhard
Keywords: osteogenesis imperfecta, skeletal phenomics, type I collagen, type I collagenopathies, zebrafish models
MeSH Terms:
  • Animals
  • Animals, Genetically Modified
  • Collagen Type I*/genetics
  • Collagen Type I*/metabolism
  • Disease Models, Animal*
  • Ehlers-Danlos Syndrome*/genetics
  • Ehlers-Danlos Syndrome*/metabolism
  • Ehlers-Danlos Syndrome*/pathology
  • Humans
  • Osteogenesis Imperfecta*/genetics
  • Osteogenesis Imperfecta*/metabolism
  • Osteogenesis Imperfecta*/pathology
  • Zebrafish*/genetics
  • Zebrafish*/metabolism
PubMed: 30082390 Full text @ Proc. Natl. Acad. Sci. USA
FIGURES
ABSTRACT
The type I collagenopathies are a group of heterogeneous connective tissue disorders, that are caused by mutations in the genes encoding type I collagen and include specific forms of osteogenesis imperfecta (OI) and the Ehlers-Danlos syndrome (EDS). These disorders present with a broad disease spectrum and large clinical variability of which the underlying genetic basis is still poorly understood. In this study, we systematically analyzed skeletal phenotypes in a large set of zebrafish, with diverse mutations in the genes encoding type I collagen, representing different genetic forms of human OI, and a zebrafish model resembling human EDS, which harbors a number of soft connective tissues defects, typical of EDS. Furthermore, we provide insight into how zebrafish and human type I collagen are compositionally and functionally related, which is relevant in the interpretation of human type I collagen-related disease models. Our studies reveal a high degree of intergenotype variability in phenotypic expressivity that closely correlates with associated OI severity. Furthermore, we demonstrate the potential for select mutations to give rise to phenotypic variability, mirroring the clinical variability associated with human disease pathology. Therefore, our work suggests the future potential for zebrafish to aid in identifying unknown genetic modifiers and mechanisms underlying the phenotypic variability in OI and related disorders. This will improve diagnostic strategies and enable the discovery of new targetable pathways for pharmacological intervention.
ADDITIONAL INFORMATION